دورية أكاديمية
A Targeted Review of Vancomycin Use
| العنوان: | A Targeted Review of Vancomycin Use |
|---|---|
| المؤلفون: | Piquette, Rosemary K. |
| المصدر: | Canadian Journal of Hospital Pharmacy; Vol. 44 No. 2 (1991) ; Le Journal canadien de la pharmacie hospitalière; Vol. 44 No. 2 (1991) ; 1920-2903 ; 0008-4123 |
| بيانات النشر: | Canadian Society of Hospital Pharmacists |
| سنة النشر: | 1991 |
| المجموعة: | The Canadian Journal of Hospital Pharmacy (CJHP) / Le Journal canadien de la pharmacie hospitalière (JCPH) |
| مصطلحات موضوعية: | vancomycin, drug utilization review, cost containment, penicillin allergy, vancomycine, maîtrise de coût, allergie à la pénicilline, revue d'utilisation de médicament |
| الوصف: | In recent years vancomycin usage at the Ottawa Civic Hospital has been steadily increasing. In an effort to determine the reason for this resurgence, and whether or not it is justified, a prospective assessment of vancomycin utilization was performed. All new orders for vancomycin received in the pharmacy in a two-month period were evaluated against predetermined criteria for appropriate use, which were developed in conjunction with Infectious Diseases and Cardiac Surgery.Of the 55 orders evaluated during the study period, 32 (58.2%) were considered inappropriate, translating to a cost of approximately $5,500.00 for the seven-week period. Use of vancomycin in penicillin-allergic patients without a confirmed history of IgE-mediated reaction, was responsible for the majority of vancomycin prescribed unnecessarily (~66%).As a result of the review's findings, the following actions were taken by the Pharmacy and Therapeutics Committee: (1) vancomycin was restricted to specific indications; (2) vancomycin will be prospectively monitored by the Pharmacy Department; (3) physician education on approved indications and dosing of vancomycin; and (4) development of guidelines for assessment and prescribing in penicillin-allergic patients.RÉSUMÉL'utilisation de vancomycine à l'Hôpital Civique d'Ottawa a augmenté progressivement ces dernières années. Afin de déterminer la raison de cette augmentation, et si elle est justifiée ou non, une évaluation prospective d'utilisation de vancomycine a été effectuée. Toutes les nouvelles ordonnances de vancomycine parvenues à la pharmacie pendant une période de deux mois étaient évaluées selon les critères prédéterminés d'utilisation appropriée, élaborés conjointement avec les départements de Maladies Infectieuses et de Cardiochirurgie.Sur les 55 ordonnances évaluées pendant la période d'étude, 32 (58.2 pour cent) étaient considérées inappropriées, traduisant un coût à environ 5,500$ pour une période de sept semaines. L'utilisation de vancomycine chez les patients allergiques à ... |
| نوع الوثيقة: | article in journal/newspaper |
| وصف الملف: | application/pdf |
| اللغة: | English |
| العلاقة: | https://www.cjhp-online.ca/index.php/cjhp/article/view/2698/3693Test; https://www.cjhp-online.ca/index.php/cjhp/article/view/2698Test |
| DOI: | 10.4212/cjhp.v44i2.2698 |
| الإتاحة: | https://doi.org/10.4212/cjhp.v44i2.2698Test https://www.cjhp-online.ca/index.php/cjhp/article/view/2698Test |
| حقوق: | Copyright (c) 2018 The Canadian Journal of Hospital Pharmacy |
| رقم الانضمام: | edsbas.890B38B2 |
| قاعدة البيانات: | BASE |
| DOI: | 10.4212/cjhp.v44i2.2698 |
|---|